Abstract. Surveillance of mosquito populations for virus activity is not often performed by small, vector-control districts because they do not have the financial resources to use virus isolation, or newer methods such as the polymerase chain reaction. Consequently, development and refinements of rapid, sensitive, and simple enzyme-linked immunosorbent assays (ELISAs) applicable to a wide variety of public health settings are justified. We have developed an antigen-capture ELISA for the detection of eastern equine encephalitis (EEE) virus in mosquitoes that uses both monoclonal capture and detector antibodies. The sensitivity of this assay is 4.0-5.0 log 10 plaque-forming units/ml, which is comparable to previously published EEE antigen-capture assays developed with polyclonal antibody reagents. This test identifies only North American strains of EEE virus and does not react with either western equine encephalitis or Highlands J viruses. Test sensitivity was enhanced by sonicating mosquito pools, treating them with Triton X-100, and increasing the time and temperature of antigen incubation. The conversion of this ELISA to a monoclonal antibody-based format should result in a readily standardizable and transferable assay that will permit laboratories lacking virus isolation facilities to conduct EEE virus surveillance.
INTRODUCTION
Alphaviruses are small, positive-stranded RNA viruses of the family Togaviridae. The nucleic acid is enclosed in an icosahedral nucleocapsid composed of multiple copies of a single capsid (C) protein. The virus is enveloped, and the envelope contains trimers of a heterodimer of two glycoproteins: E1 and E2. 1 In the United States, the alphaviral encephalitides (eastern equine encephalitis [EEE] and western equine encephalitis [WEE] ) are still significant public health concerns causing both human and equine encephalitis, often with high case fatality rates. 2 Between 1964 and 2000, 178 human cases of EEE were reported to the Centers for Disease Control and Prevention (CDC). In North America, EEE virus is found primarily in the eastern United States and is transmitted between Culiseta melanura mosquitoes and birds in an enzootic cycle. [3] [4] [5] Coquillettidia perturbans, Aedes sollicitans, and Aedes vexans are the primary mosquito vectors that transmit the virus from infected birds to humans and equines. 6 Disease risk can often be assessed by monitoring rates of virus infection in vector mosquitoes. Various interventions ranging from public health alerts to extensive mosquito control can then be used to decrease the disease risk. The current method of identifying alphaviruses in mosquitoes is by pooling and triturating collected mosquitoes, followed by inoculation of cell cultures, or suckling mice for isolation. Infected tissue is then harvested and the virus is identified either by indirect imunofluorescence assay (IFA) or neutralization of virus infectivity using virus typing antisera. 7, 8 These procedures are costly, time-consuming, and laborious. Furthermore, many state health laboratories and mosquito control districts do not have the facilities to maintain cell cultures. Therefore, enzyme-linked immunosorbent assays (ELISAs) to detect arboviruses in pools of infected mosquitoes and infected animal tissues have been developed. [9] [10] [11] [12] [13] [14] [15] [16] These tests are rapid, sensitive, and cost-effective. However, the ELISAs developed for EEE virus-infected mosquitoes have used hyperimmune polyclonal reagents that are difficult to standardize between laboratories. 17 In the context of surveillance for arboviruses of public health importance, standardization of laboratory results is critical.
We have previously produced monoclonal antibodies (MAbs) against a variety of alphaviruses. 8, 18, 19 Many of these MAbs have been used in ELISAs and IFAs for identification of EEE virus. We report here the development of an antigencapture ELISA for EEE viruses using MAbs specific for the E1 glycoprotein. This test is standardizable, reproducible, sensitive, and readily detects EEE virus with suitable sensitivity and specificity to be used in surveillance for EEE virus-infected mosquitoes.
MATERIALS AND METHODS
Viruses. Prototype EEE virus (strain NJ/60) was grown in Vero cells and purified as described previously. 20 Stock viral seeds and suckling mouse brain (SMB) antigens of other EEE viruses, WEE (McMillan) virus, and Highlands J (HJ, strain SM66) virus were obtained from the Arbovirus Diseases Branch, Division of Vector-Borne Diseases (CDC). The EEE virus strain used for mosquito inoculation was 82V-3167.
Antibodies. The isolation and characterization of the murine MAbs used in this assay have been described. 8 The MAb 1B5C-3 is an IgG1 antibody that is specific for North American EEE viruses and reacts with the E1glycoprotein. The MAb 1A4B-6 is an IgG2b antibody that reacts with an E1 epitope shared by all alphaviruses.
Mosquito inoculation and incubation. Female Aedes aegypti, 3-5 days of age, from a colony strain originating in Lake Charles, LA were used for intracoelomic inoculation. Measured volumes of 0.17 l of virus dilutions calculated to deliver approximately 70 Vero cell plaque-forming units (PFU) per dose were inoculated into individual mosquitoes. Groups of mosquitoes were inoculated on separate occasions, and back titration of inocula indicated that mosquitoes actually received 34-65 PFU each. Groups of five mosquitoes each were placed in half-pint cages. One group of mos-quitoes was frozen at Ϫ70ЊC immediately after inoculation and the remaining groups were incubated at 26.7ЊC with a relative humidity of 85%, and a photoperiod of 15:9 (light: dark). One group of mosquitoes was frozen at approximately 2-hr intervals during the first 24-hr post-inoculation and less frequently thereafter through day 6 post-inoculation. Some infected mosquitoes were processed and tested individually as described below, whereas others were used to make pools containing one infected mosquito and 24, 49, or 99 uninfected colony mosquitoes. Individual infected mosquitoes and mosquito pools were processed and tested as follows. Mosquitoes were titurated in 2 ml of BA-1 diluent (0.2 M Tris, pH 8.0, 0.15 M NaCl, 1% bovine serum albumin, 10 mg/L of phenol red, 50 g/l of gentamicin, and 1 g/ml of fungizone (Bristol Myers Squibb, New York, NY) using cold mortars and pestles and sterile alundum. Suspensions were centrifuged in 1.5 ml conical microcentrifuge tubes at 14,000 rpm for 2 min. Supernatants to be tested for virus by plaque assay in Vero cell culture were poured into 1-dram screw-cap vials and stored at Ϫ70ЊC until tested as previously described. 21 The microfuge tubes containing pellets and the remaining supernatant were resuspended, then sonicated at 100 W for 10 sec. The tubes were centrifuged at 14,000 rpm for 2 min, and the supernatant was transferred to a new vial. For the final ELISA protocol, immediately prior to ELISA testing, 10 l of lysis buffer (5% Tween 20 in phosphate-buffered saline [PBS]) per 100 l mosquito pool supernatant was added and allowed to incubate for 15 min at room temperature. The samples were centrifuged at 14,000 rpm for 2 min and the supernatant from this centrifugation was the antigen used in the ELISA.
Enyme-linked immunosorbent assay. In the final protocol for the antigen-capture ELISA, 96-well Immulon 2 microtiter plates (Dynex Technologies, Chantilly, VA) were coated with 100 l of capture MAb 1A4B-6 diluted 1:20,000 in carbonate buffer, pH 9.6, and stored overnight or until needed at 4ЊC. 14 Plates were washed five times with rinse buffer (0.05% Tween 20 in PBS), then blocked with 300 l of 1% skim milk and 0.1% Tween 20 in PBS for 1 hr at 37ЊC. Plates were then washed as above, and 100 l of sonicated, detergent-treated mosquito pool antigen was added to each well and incubated overnight at 37ЊC. Pools were tested in duplicate or triplicate when enough material was available. Positive controls and at least six uninfected mosquito pools were run in each test. Plates were washed five times and 100 l of a detector MAb (1B5C-3) that had been commercially conjugated to horseradish peroxidase (HRP) (Jackson Immunoresearch Laboratories, West Grove, PA) diluted 1:1,000 in rinse buffer was added. After a 1-hr incubation at 37ЊC, the plates were washed 10 times and 100 l of 3,3Ј,5,5Ј-tetramethlybenzidine was added. The plates were allowed to incubate in the dark for 30 min before the reaction was stopped by the addition of 50 l of 1N H 2 SO 4 . The absorbance was measured in a microplate reader at 450 nm (Bio-Rad Laboratories, Hercules, CA). When ELISA plates are precoated with capture antibody and stored at 4ЊC prior to use, this antigen-capture assay can be performed in less than 24 hr.
Inhibition test. The capture-inhibition test was formulated following our previous protocol with Saint Louis encephalitis (SLE) virus. 14 Mosquito pools were incubated for 1 hr at 37ЊC with a homologous hyperimmune anti-EEE virus mouse hyperimmune ascitic fluid (MHIAF) or a control mouse ascitic fluid prepared against SLE virus. This mixture was then retested in the ELISA. Pools were considered positive when the absorbance value of the pool with homologous mouse ascitic fluid was reduced by 50% compared with the value of the pool with SLE virus mouse ascitic fluid.
Data analysis. The mean absorbance for each pool and the normal controls were calculated. The pools with a mean absorbance value greater than twice the mean of the normal controls were interpreted as positive. Positive pools were tested in the inhibition test to confirm the presence of virus antigen.
RESULTS

Identification of MAb detector.
We previously identified and characterized a number of murine MAbs reactive with EEE virus. 8 We selected MAb 1B5C-3, which reacts with the E1 glycoprotein of North American isolates of EEE virus, as an initial detector antibody for further test development. The MAb from the mouse ascitic fluid was purified and conjugated to HRP.
Identification of a polyclonal capture antibody and formulation of the antigen-capture ELISA. To compare test performance, we first developed an antigen-capture ELISA using a polyclonal anti-EEE virus capture antibody. Thirteen anti-EEE virus polyclonal antibodies from various species were screened for antiviral antibody titers against purified EEE virus by indirect ELISA, and this activity was compared with their ability to function as a capture antibody, when coated to microtiter plates and using 500 ng of purified EEE virus as antigen and 1B5C-3-HRP as detector. Based on these activities and available quantities of reagents, MHIAF M20591 was selected as an antigen-capture antibody for further evaluation. This MHIAF had an end-point titer of 256,000 in the indirect ELISA and 12,800 in the antigen-capture ELISA. To optimize the use-dilution of the 1B5C-3-HRP detector, wells were coated with a constant amount of capture antibody (1:1,000 of M20591), followed by a constant amount of antigen (500 ng/well of purified EEE virus) and a dilution series of the 1B5C-3-HRP conjugate. In this way, the optimal use-dilution of the 1B5C-3-HRP conjugate was determined to be 1:1,000.
Determination of capture MAb specificity and sensitivity. The sensitivity of this ELISA was determined by a boxed titration of capture antibody and virus using either samples of purified virus and a viral seed of known titer. This assay detected 20 ng or 4.3 log 10 PFU/1.0 ml of EEE virus. The specificity of the ELISA was confirmed by using viral seeds or virus-infected SMB of various EEE, WEE, and HJ viruses. This ELISA detected only North American isolates of EEE virus ( Figure 1 ) and did not detect either WEE or HJ virus (Figure 2) , which was expected because of the previously published specificity of the 1B5C-3 MAb. In the latter experiment, a broadly cross-reactive alphavirus MAb-HRP conjugate (2A2C-3-HRP) was also used in parallel tests, and demonstrated that both WEE and HJ viruses had been captured successfully by the 1A4B-6 antigen-capture MAb.
Conversion of the antigen-capture ELISA to a com- plete MAb format. The polyclonal ELISA antigen-capture antibody was next converted to an MAb. To do this, a number of MAbs were substituted for the M20591 MHIAF in tests using 500 ng of purified virus as antigen and a 1:1,000 dilution of 1B5C-3-HRP as detector. Based on this analysis, the broadly alphavirus-reactive MAb 1A4B-6 was selected as a MAb antigen-capture antibody. To determine the best use-dilution of MAb 1A4B-6, dilutions of both 1A4B-6 and M20591 were tested in the antigen-capture system using virus in two forms: tissue culture seed virus or virus-infected SMB (Figure 3 ). With both of these antigens, the MAb gave higher A 450 nm readings than the polyclonal antibody M20591. Based on this titration, the 1A4B-6 capture MAb was subsequently used at a 1:20,000 dilution. The antigen sensitivity was then compared for 1A4B-6 and M20591 by using both tests with a dilution series of virus tissue culture seed. While the antigen end-points for both capture antibodies were similar (4.0 log 10 PFU/1.0 ml), the A 450 nm for the MAb capture system was much higher than that of the polyclonal antibody antigen-capture system. This result probably reflects the homogeneity of the MAb and its higher binding avidity. Similar results were observed when purified virus was used as antigen.
Optimization of antigen dissociation in mosquito pools. Because this test is based upon reactivity with viral integral membrane protein E1, we attempted to increase the test sensitivity by introducing two other disruption procedures: sonication and nonionic detergent lysis. Sonication was used to disrupt larger amounts of mosquito tissue. Treatment of alphavirus-infected cells at neutral pH with nonionic detergents will release viral proteins without disrupting the cell nucleus. Disruption of the nuclear membrane happens when charged detergents are used (e.g., sodium dodecyl sulfate), releasing cellular DNA into solution and causing the lysate to thicken until the DNA is mechanically fragmented. Two incubation procedures were also used to analyze the effect that longer incubation of the mosquito pools in the test might have on test sensitivity ( Table 1) . Inclusion of sonication, detergent lysis, and extended incubation times of the mosquito pools in the test increased the absorbance of test specimens by three-fold compared with nontreated controls. Also, addition of Tween 20 to the mosquito pools had the added benefit of reducing the test background, presumably by reducing nonspecific absorption.
Sensitivity of the antigen-capture test for virus in EEE virus-infected mosquitoes. Mosquito pools were experimentally infected with EEE virus as described in the Materials and Methods, and then tested by both polyclonal and monoclonal antigen-capture ELISAs and virus isolation. The sensitivities of both ELISAs were similar; therefore, only the data for the MAb capture assay is shown (Figure 4 ). Virusinfected mosquito pools became positive after about 10-12 hr of extrinsic incubation, with peak virus titers of approx- imately 6.0 log 10 PFU/0.1 ml. The increase in absorbance in the antigen-capture ELISA post-inoculation was similar to the increase in virus plaque titers. The test sensitivity for detection of EEE virus in mosquito pools was somewhat less than that determined previously in the liquid assay. During our attempts to standardize the dissociation protocol, we noticed that preparing a pool of one infected with 24 uninfected mosquitoes (''C'' pools) resulted in a slighter, but measurable decrease in the A 450 nm than when a single infected mosquito of comparable virus titer was processed alone (''A'' pools) ( Table 1 ). To analyze this dilution effect further, pools of mosquitoes were prepared that contained a single infected specimen mixed with 49 or 99 uninfected mosquitoes ( Table 2) . Addition of 49 uninfected mosquitoes increased the signal quenching even more than 24 uninfected mosquitoes. Addition of 99 uninfected mosquitoes blocked the signal from the virus-infected single mosquito. For optimum sensitivity, we recommend mosquito pool sizes of 25; however, for economy of handling, adequate sensitivity is still maintained with mosquito pool sizes of 50. Inhibition assay for presence of virus in mosquito pools. To confirm the specificity of a positive result in this antigen-capture system, it must be possible to quench the positive signal by preincubating a portion of the mosquito pool with specific antiviral antibodies prior to testing. Quenching of the signal should not occur when the mosquito pool is incubated with a heterologous antiviral antibody. To perform the inhibition test, we used a polyclonal anti-EEE virus HIAF as our positive (homologous) control and an anti-SLE virus HIAF as our negative (heterologous) control. The comparative absorbance in homologous inhibition was routinely reduced by 50% or greater when compared with the absorbance in the heterologous inhibition assay. We, therefore, assumed a 50% or greater difference in inhibition as an indicator of EEE virus-specific capture.
DISCUSSION
The advantages of the ELISA over viral isolation in surveillance are numerous and have been well documented. The ELISA facilitates rapid processing of a large number of samples, allowing time to implement vector control strategies if necessary. It is cheaper than the polymerase chain reaction and requires only a plate reader. The ELISA is also simpler and less expensive to perform than isolation and identification by the IFA. It must be said, however, that for labora-tories with cell culture facilities, the exquisite sensitivity of continuous tissue cell cultures to alphaviruses and the availability of virus-specific MAb reagents such as 1B5C-3, do permit virus identification in 24-36 hr post-infection using the IFA.
Design of an MAb-based antigen-detection ELISA can follow two formats: the capture antibody can be virus specific, while the detector antibody-conjugate can be broadly cross-reactive. This is the format that was used in our development of the SLE virus antigen-detection system. Using a broadly cross-reactive detector antibody also limits the number of enzyme conjugates needed to identify a variety of related antigens. It seems, however, that the rate-limiting step in developing antigen-capture assays is the availability of satisfactory capture antibodies that have to be identified empirically, as we have done in this study. The use of the alphavirus cross-reactive MAb 1A4B-6 as capture antibody facilitates adaptation of this test to other medically important alphaviruses, such as WEE virus.
All previously published antigen-detection ELISAs for EEE virus-infected mosquitoes have used polyclonal antibodies. Only one study analyzed a North American EEE virus-specific MAb (1B4A-6) as a suitable capture antibody. 16 While this MAb had a capture sensitivity similar to that of polyclonal antibodies, it was not selected for further use. Polyclonal reagents may vary from batch to batch and lack the specificity of MAbs. The ELISA test described here is unique because of the use of MAbs directed to the E1 glycoprotein of EEE virus. The specificity of our protocol allows us to identify specific EEE viruses originating in North America. A genus-specific antigen-capture ELISA using MAbs was developed for alphavirus detection from cell culture seed virus. 22 The sensitivity of this assay for virus was similar to our antigen-capture assay; however, this assay was never used to detect virus in mosquito pools.
To assess fairly the relative sensitivities of polyclonal antibody and MAb-based ELISAs, we developed and compared both systems. In identifying virus from infected mosquito pools, both systems demonstrated similar sensitivities (5.0 log 10 PFU/0.1 ml). This sensitivity was obtained by sonicating and treating mosquito pools with Tween 20. This level of sensitivity is similar to the antigen-capture ELISAs reported previously for EEE virus in infected mosquitoes. 9, 10 It should be noted, however, that volume dimensions were never mentioned in the previously published EEE antigencapture ELISAs, so direct sensitivity comparisons are difficult. A study analyzing the replication levels of EEE virus in its primary mosquito vector (Culiseta melanura) demonstrated virus titers ranging from 5.0 to 7.0 in virus-infected mosquitoes. Because dilution of an infected mosquito with up to 49 uninfected mosquitoes still results in a positive ELISA signal, a test with a sensitivity of 5.0 log 10 PFU should be sufficient for routine identification of most virusinfected mosquito pools.
Our EEE antigen-capture ELISA is less sensitive than the antigen-capture ELISA we developed for SLE virus. The reason for this is unknown; however, significant differences do occur in how alphaviruses and flaviviruses replicate in mosquitoes. It is quite likely that these replication differences account for the observed differences in sensitivity between the antigen-capture ELISAs. These differences in replication are also probably reflected in the differing effects that sonication and detergent treatment have on the SLE virus and EEE virus antigen-capture ELISAs. While these test modifications increased the sensitivity of the EEE virus ELISA, neither treatment significantly enhanced the sensitivity of the SLE virus antigen-capture ELISA.
The conversion of the EEE virus-specific, antigen-capture ELISA to an MAb-based format results in a readily standardizable and transferable assay. This assay will assist small vector-control agencies without cell culture facilities in assessing the EEE virus threat. The specificity of this assay also permits rapid differentiation of mosquitoes infected with HJ versus EEE virus. Highlands J virus, which also circulates in mosquitoes in the eastern United Sates, is not, as yet, an important human pathogen. The close serologic relatedness of HJ and EEE viruses can confuse test interpretation. We are currently adapting this assay for use with WEE virus, and we are also adapting this ELISA to a dipstick format, which will further economize its application to a small number of samples.
